In various cancer cell lines, CARTPT acts as an oncogene, promoting cellular survival through the activation of the ERK pathway, stimulation of pro-survival molecules, inhibition of apoptosis, and an increase in cyclin D1 levels. Here, CCND1 is linked to cancer.